SCHEMBL7811461

SCHEMBL7811461

CC(C)(Oc1ccc(C2=CCN(C(=O)c3ccc(F)cc3)CC2)cc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 4/20 0.52
PPARG P37231 3/20 0.51
PPARA Q07869 3/20 0.51
ALOX15 P16050 2/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
CASP3 P42574 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
HSD11B1 P28845 1/20 0.43
SIGMAR1 Q99720 2/20 0.43
ITGB3 P05106 1/20 0.42
ITGA2B P08514 1/20 0.42
CYP2D6 P10635 1/20 0.42
THPO P40225 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7804408 0.91 PPARA (0.53) NAMPTPPARGPPARAALOX15ALDH1A1
SCHEMBL7811809 0.90 NAMPT (0.57) NAMPTPPARGPPARAALOX15ALDH1A1
SCHEMBL7804727 0.90 PPARG (0.53) NAMPTPPARGPPARAALOX15ALDH1A1
SCHEMBL7809900 0.89 PPARA (0.49) NAMPTPPARGPPARAHPGD
SCHEMBL7817567 0.89 PPARA (0.64) NAMPTPPARGPPARAALDH1A1MAPT
SCHEMBL7813924 0.89 PPARA (0.51) NAMPTPPARGPPARAALOX15MAPT
SCHEMBL7813581 0.89 PPARA (0.51) NAMPTPPARGPPARAALOX15ALDH1A1
SCHEMBL7811760 0.89 PPARG (0.49) NAMPTPPARGPPARAALOX15NPC1
SCHEMBL7811694 0.88 PPARG (0.52) NAMPTPPARGPPARAALDH1A1SMN1; SMN2
SCHEMBL7817615 0.85 PPARG (0.48) NAMPTPPARGPPARAALOX15NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed